ANDA submission

An ANDA is a submission to the U.S. Food and Drug Administration (FDA) requesting approval to market a generic drug by demonstrating that it is pharmaceutically equivalent and bioequivalent to a previously approved Reference Listed Drug (RLD). The generic drug must match the RLD in active ingredient(s), dosage form, strength, route of administration, labeling, and clinical performance.